CM Life Sciences II Inc. (CMII) Shareholders Approve SomaLogic Deal
CM Life Sciences II Inc. (NASDAQ:CMIIU) announced in an 8-K filing today that its shareholders approved its combination with proteomics firm SomaLogic at a meeting yesterday. The filing did not include redemption details, but CM II may have been safer than other SPACs heading to close this month as it opened at $9.99 on itsRead More